Kris Jacobs Vacancies Kris Jacobs Kris Jacobs Loading jobs... Stay updated Sign up to stay updated and find out how you can get involved. Email Address Data protection consent Read, watch, share Filter by - Any -BlogEventsExplainerFact sheetFeature storyInfographicInterviewIssue briefLetterNewsletterOpinion articlePhoto storyPress releaseReportReport seriesResearch articleSpeechSpotlightStatementTechnical briefTopic overviewVideo Letter | 21 September 2023 Tuberculosis Azerbaijan Azerbaijan: Open Letter: CSOs request urgent action by Johnson & Johnson to improve equitable access to bedaquiline-based regimens in all countries with a high burden of tuberculosis Letter | 21 September 2023 Intellectual property and trade Ukraine Ukraine: Open Letter: Urgent action by Johnson & Johnson needed to improve equitable access to bedaquiline-based regimens in all countries with a high burden of tuberculosis Letter | 21 September 2023 Intellectual property and trade Republic of Moldova Moldova: Open Letter: CSOs request urgent action by Johnson & Johnson to improve equitable access to bedaquiline-based regimens in all countries with a high burden of tuberculosis Letter | 21 September 2023 Tuberculosis Ukraine Ukraine: Open Letter: CSOs request urgent action by Johnson & Johnson to improve equitable access to bedaquiline-based regimens in all countries with a high burden of tuberculosis Photo credit: Paul Odongo/MSF Statement Statement | 20 September 2023 Pandemic preparedness MSF reaction statement to UNHLM PPPR declaration 3 min Photo credit: Tracy Makhlouf/MSF Statement Statement | 20 September 2023 Pandemic preparedness MSF statement on UN pandemic preparedness meeting and declaration 6 min Photo credit: Borja Ruiz Rodriguez/MSF Press release Press release | 19 September 2023 Tuberculosis TB test price reduction by Cepheid and Danaher is an important step in the right direction 3 min Technical brief | 15 September 2023 Pandemic preparedness Intellectual property and trade From TRIPS to PPR: Addressing Intellectual Property Barriers on Lifesaving Medical Products Load More
Letter | 21 September 2023 Tuberculosis Azerbaijan Azerbaijan: Open Letter: CSOs request urgent action by Johnson & Johnson to improve equitable access to bedaquiline-based regimens in all countries with a high burden of tuberculosis
Letter | 21 September 2023 Intellectual property and trade Ukraine Ukraine: Open Letter: Urgent action by Johnson & Johnson needed to improve equitable access to bedaquiline-based regimens in all countries with a high burden of tuberculosis
Letter | 21 September 2023 Intellectual property and trade Republic of Moldova Moldova: Open Letter: CSOs request urgent action by Johnson & Johnson to improve equitable access to bedaquiline-based regimens in all countries with a high burden of tuberculosis
Letter | 21 September 2023 Tuberculosis Ukraine Ukraine: Open Letter: CSOs request urgent action by Johnson & Johnson to improve equitable access to bedaquiline-based regimens in all countries with a high burden of tuberculosis
Photo credit: Paul Odongo/MSF Statement Statement | 20 September 2023 Pandemic preparedness MSF reaction statement to UNHLM PPPR declaration 3 min
Photo credit: Tracy Makhlouf/MSF Statement Statement | 20 September 2023 Pandemic preparedness MSF statement on UN pandemic preparedness meeting and declaration 6 min
Photo credit: Borja Ruiz Rodriguez/MSF Press release Press release | 19 September 2023 Tuberculosis TB test price reduction by Cepheid and Danaher is an important step in the right direction 3 min
Technical brief | 15 September 2023 Pandemic preparedness Intellectual property and trade From TRIPS to PPR: Addressing Intellectual Property Barriers on Lifesaving Medical Products
